Glen Weiss to Antibodies, Monoclonal
This is a "connection" page, showing publications Glen Weiss has written about Antibodies, Monoclonal.
Connection Strength
0.403
-
Weiss GJ, Zeng C, Kelly K, Tran ZV, Bunn PA. Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer. Clin Lung Cancer. 2007 Mar; 8(5):335-8.
Score: 0.192
-
Weiss GJ, Addeo A. Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. N Engl J Med. 2019 02 28; 380(9):888-889.
Score: 0.110
-
Lam ET, Eckhardt SG, Messersmith W, Jimeno A, O'Bryant CL, Ramanathan RK, Weiss GJ, Chadha M, Oey A, Ding HT, Culp PA, Keller SF, Zhao VY, Tsao LC, Singhal A, Holen KD, Von Hoff D. Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors. Mol Cancer Ther. 2018 01; 17(1):215-221.
Score: 0.100